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INTRODUCTION
Birt-Hogg-Dube syndrome (BHDS) is an inherited auto-
sominal dominant genodermatosis that predisposes individ-
uals to the development of fibrofolliculomas (FF), trichodis-
comas (TD), and acrochordons of the face, neck, and upper
trunk (1). There is also an increased risk for lung cysts, spon-
taneous pneumothorax, and renal carcinomas in affected peo-
ple, and some patients may also develop colorectal polyps
and cancers (2-4). The disease is caused by germline muta-
tions in the BHD (also known as FLCN) gene located in
17p11.2 encoding folliculin, a new protein with unknown
function (5). We report a patient with BHDS in which muta-
tion analysis subsequently revealed a novel mutation.
CASE REPORT
A 31-yr-old woman visited the Department of Dermatology
for evaluation of long-standing mildly pruritic facial papules
that she had had for 10 yr (Fig. 1). Previously she had been
treated with CO2 laser and Aldara ointment with the impres-
sion of verruca or syringoma but with little effect. Physical
examination revealed several firm, flesh-colored, dome-shaped,
papular lesions ranging from 2 to 5 mm in diameter, dis-
tributed on the face and neck area. The patient had a history
of pneumothorax; otherwise, her medical history was not
notable. Skin biopsies of the facial papules were performed.
One sample showed concentric layers of cellular fibrous tis-
sue around hair follicles with an aritifactual cleft separating
the fibroma from adjacent connective tissue (Fig. 2A). Also
in another sample, a raised papule composed of connective
tissue surrounded by a lateral collarette was seen (Fig. 2B).
Staining with alcian blue and elastin stain revealed an unen-
capsulated loosely woven admixture of collagen and thin
elastic fibers with mucin. Periodic acid-schiff (PAS) staining
showed multiple thin and thick walled blood vessels with
PAS-positive basement membrane within the substane of
the tumor. The biopsy findings were consistent with peri-
follicular fibroma and trichodiscoma, respectively.
Computed tomographic scan of the chest, abdomen, and
pelvis showed multiple cysts on both lower lung zone, with
sizes ranging from 1.4-2.4 cm and a small amount of pneu-
mothorax noted on the left anterior basal hemithorax. The
scan did not show any abnormalities in the kidney or colon.
There was no family history of renal tumors, colon carcino-
ma, or other benign or malignant neoplasm. However, the
patient reported that her two aunts died of ‘lung disease’ (diag-
nosis unknown) and one of her older sisters was remembered
to have had multiple tumorous lesions. Both of her older sis-
ters passed away at an early age but she did not know the
cause of death. 
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A Case of Birt-Hogg-Dube Syndrome
Birt-Hogg-Dube syndrome (BHDS) is an autosomal dominant genodermatosis char-
acterized by cutaneous hair follicle tumors (fibrofolliculoma or trichodiscoma), pul-
monary cysts, and increased risk of renal neoplasia. The genetic alteration for BHDS
has been mapped to chromosome 17p12q11, and the gene in this region has been
cloned and believed to be responsible for the BHDS. Mutations in the BHD gene
(also known as FLCN) have been described in the patients with BHDS. We pre-
sent a case of a 30-yr-old Korean woman with multiple mildly pruritic papules on
her face and neck area. The patient had several firm, flesh-colored, dome-shaped,
papular lesions measuring between 2 to 5 mm. Except for a history of pneumotho-
rax her medical records were not remarkable. Mutation analysis of the BHD gene
was performed, and a novel deletion mutation (p.F519LfsX17 [c.1557delT]) caus-
ing truncation of the gene product, folliculin, was found in the exon 14. The actual
incidence of BHDS is unknown, but it is most likely underdiagnosed. So it is imper-
ative that doctors recognize the skin lesions of BHDS and institute proper screen-
ing to detect other manifestations of the disease. Here, we report a case of BHDS
with a novel mutation, which is the first report in Korea.
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Molecular analysis of the BHD gene was performed after
informed consent from the patient. Genomic DNA was ex-
tracted from peripheral blood leukocytes, and subjected to
mutation analysis. All the coding regions of the BHD gene
(exons 4-14) were amplified using polymerase chain reaction
(PCR) with oligonucleotide primers we designed (Table 1).
The amplified PCR products were sequenced using the ABI
3100 Genetic Analyzer (Applied Biosystems/Hitachi, Fos-
ter City, CA, U.S.A.). Sequencing analysis revealed a novel
deletion mutation (p.F519LfsX17 [c.1557delT]) in the BHD
gene exon 14 of the patient (Fig. 3). This mutation results
in producing the truncated protein folliculin, which is caused
by frameshift of amino acid sequence in the BHD gene prod-
uct. Also, this deletion mutation has not yet been found in
the normal populations, indicating that this mutation is the
real cause of the syndrome in this case.
DISCUSSION
BHDS was recently found to be caused by heterozygous
loss-of-function mutations in the BHD tumor suppressor gene
on chromosome 17p11.2, which encodes the novel protein
folliculin. Mutations are predicted to result in truncation of
folliculin. Fluorescent in situ hybridization has shown the
expression of BHD mRNA in many normal tissues including
the skin and its appendages, the distal nephron of the kidney,
stromal cells, and type 1 pneumocytes of the lung (6). The
function of the BHD gene in tumorigenesis, however, has not
yet been elucidated. The defective protein in patients with
BHDS may affect the cell’s cytoskeleton, disrupting the extra-
Fig. 1. Multiple small dome-shaped, flesh-colored papules on the
face and neck.
Fig. 3. Sequence analysis of the Birt-Hogg-Dube gene, showing
deletion of a thymidine in the exon 14 (c.2012delT). 
Fig. 2. (A) Concentric layers of cellular fibrous tissue around hair
follicles representing perifollicular fibroma (hematoxylin-eosin stain;
original magnification ×40, inset ×200). (B) Raised papule com-
posed of connective tissue surrounded by a lateral collarette rep-
resenting trichodiscoma (hematoxylin-eosin stain; original magni-
fication ×40, inset ×200).
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Normal allele
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+
Exon Primer name Primer sequence
4 FLCN-E4-f TCATGGAGTC AATAGGCATT GGCA
FLCN-E4-r TGCAGTGAGC CATGATCACA CCAT
5 FLCN-E5-f GTTACCTACT TCGTAAGTGC TCAGC
FLCN-E5-r CCTGTGCAAT GCTGGCTCCG AGC
6 FLCN-E6-f AGAGTACAGT CTTCGGCTCT CATGG
FLCN-E6-r ACAATTCACA CAGTGCACTG GCTG
7 FLCN-E7-f TCCAGGAGTC AGGTCCTGGA GTT
FLCN-E7-r CAGATCTGTG CTCACTGACA AGTG
8 FLCN-E8-f GTTGACTTGT GGAACTGCCT GCAT
FLCN-E8-r CTCGTTCTGG GCTGATTCAG AGC
9 FLCN-E9-f CCAGGAATCT ACACTGACCG GCT
FLCN-E9-r GAGGCTGTCA GTCACTTCCT GCA
10 FLCN-E10-f GCCTCCCTGA GAAGATAAGT GTCTT
LCN-E10-r GGTGCACAGC GGTTCTGTGC T
11 FLCN-E11-f GTACAAGCTG GTGTGTGACT GGC
FLCN-E11-r TCTCCACAAC CCATGACAGA GATCT
12, 13 FLCN-E12,13-f ACTGACCTGG GATGAGCGGA GT
FLCN-E12,13-r ACCTGAGCTT TGCAGTGGCG GA
14 FLCN-E14-f GCTGGTGCCA AAGCCGTGTC A
FLCN-E14-r ACAGCTCCTT CCAGCAGTTG AGA
Table 1. The primer sequences used in the amplification of the
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cellular matrix and affecting the regulation of cellular prolif-
eration (7). Because patients with BHDS have inactivating
mutations in the BHD gene, and many BHDS tumors exhib-
it loss of heterozygosity, the BHD gene is considered to be a
tumor suppressor gene (7). Fluorescent in situ hybridization
showed that BHD mRNA was strongly expressed in the pro-
liferating epithelial strands of FFs but not expressed in the renal
tumors of patients with BHDS. This further supports a tumor
suppressor role for BHD in renal cancer (8). Genotype-phe-
notype correlation remains to be evaluated for BHDS, but it
was recently suggested that significantly fewer renal tumors
were observed in patients with the C-deletion than those with
the C-insertion mutation in the exon 11 hotspot (9). To date,
several different BHD germline mutations have been identi-
fied with mutations affecting all translated exons (4-11) with
the exception of exons 8 and 10. Our patient showed novel
mutation in the exon 14 (Fig. 4).
Clinical diagnosis of BHDS requires a minimum of 10 skin
lesions clinically compatible with FFs and at least one histo-
logically proven FF (5, 9). FF and TD present as asymptomat-
ic single or multiple dome-shaped papules commonly locat-
ed on the head, neck, back, and arms. Biopsy from our patient
showed features of perifollicular fibroma and trichodiscoma.
However, many researchers now consider perifollicular fibro-
ma in patients with BHDS to actually represent FF (10).
Thus, based on clinical and histological findings, our patient
could be diagnosed as BHDS.
Since its description in 1977, BHDS has been linked to
tumors of nearly every organ system. BHDS patients are 9.3
times more likely to develop a renal tumor than unaffected
persons, and are 32.3 times more likely to develop a sponta-
neous pneumothorax (12). Older age and male gender increase
the risk for renal tumors, whereas the risk of spontaneous
pneumothorax is inversely associated with age (12). Between
15% and 30% of BHDS-affected patients develop renal can-
cers (13). Because of the inherited predisposition, patients
develop renal tumors much earlier than unaffected persons,
typically developing tumors in their 20s or 30s instead of in
their 70s and often presenting with multiple, bilateral renal
cancers. In the absence of strictly defined guidelines, it is
recommended that patients with clinical manifestations of
BHDS undergo abdominal computed tomography and/or
renal ultrasound at the time of diagnosis. Interval screening
may be performed every 3 to 5 yr. Siblings should have a
complete physical examination with biopsy of lesions suspi-
cious for FF/TDs beginning in their 20s. Routine screening
for renal pathology may begin if they have FF or at age 40
yr. Tumors less than 3 cm are observed, whereas tumors larg-
er than 3 cm are treated with nephron-sparing procedures
including partial nephrectomy (14). Spontaneous pneumoth-
orax was more likely to occur in younger patients with BHDS
(12). Pneumothorax typically presents with dyspnea and chest
pain. Clinical findings include tachypnea, diminished or absent
breath sounds, and hyperresonace. Radiographic examination
confirms the diagnosis. Patients with BHDS should be in-
formed of the increased risk and educated on the signs and
Fig. 4. Distribution of mutations reported in Birt-Hogg-Dube syndrome.
1 2 3 4
c.513deIT (F)
c.707deIC (F)
c.751deIA (F)
c.1733insC (F)
c.1733deIC (F)
c.1756G>C (F)
Type of mutation
(F): Frameshift
(N): Nonsense
(S): Splice site
c.2034C>T (N)
c.458deIG (F) IVS4-1G>A (S) IVS10-2A>G (S)
c.2012deIT (F)
- novel mutation
IVS9+1G>A (S)
IVS9+2T>G (S) ATG
EXON
c.1941insCTGT (F)
c.1036deIG (F)
c.876deIC (F)
c.1087deIAGinsC (F)
c.1092deIT (F)
c.1126deIC (F)
c.1758deIT (F)
c.1834deITC (F)
c.1844C>G (N)
c.1881insG (F)
c.1884C>T (N)
c.1864-1874delGGGAGCCCTGT (F)
c.1378-1405dup (F)
c.1468deIG (F)
c.1473deIC (F)
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symptoms of pneumothorax. Our patient was diagnosed
with pneumothorax in her 20s but other concominant abnor-
malities were not found. However, as the risk of renal tumors
increases with age we advised the patient to have regular
screening. The risk for colon polyps and colon cancer was
not increased in BHDS (12), so screening for colon patholo-
gy may not be warranted. However, routine screening by
colonoscopy is included in the currently recommended guide-
line for all patients aged >50 yr. The decision to undergo
examination at an earlier age should be discussed with the
patient.
The actual incidence of BHDS is unknown, and the dis-
ease is most likely underdiagnosed. It is imperative that physi-
cians recognize the skin lesions of BHDS and institute proper
screening to detect other manifestations of the disease, such
as renal tumors and lung cysts. Patients with numerous facial
and truncal papules resembling FFs are candidates for biopsy.
In summary, we report a case of BHDS with a novel mutation,
which is the first report in Korea.
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